Please assess the completion status of the following clinical trial:

Trial Title: Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Diabetes mellitus type 2 of \>2 years duration~2. Albuminuria~Exclusion Criteria:~1. Age \>80 years~2. Myocardial infarction/unstable angina within three months prior to randomisation~3. Decompensated congestive heart failure or functional class 3 and 4.~4. Changes in dosage of any vasodilator drugs during the preceding six weeks~5. Women of fertile age.~6. Impaired hepatic function (2 times upper normal limit of aminotransferases ASAT and ALAT)~7. Ongoing treatment with glibenclamide, cyclosporin or warfarin~8. Any concomitant disease or condition that may interfere with the possibility for the patient to comply with or complete the study protocol~9. Participant in an ongoing study~10. Unwillingness to participate following oral and written information

- Gender: ALL
- Minimum Age: None
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Bosentan (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).